While both Cvac and Stimuvax target MUC-1, they have at least one key difference. Cvac is a personalised vaccine (like Dendreon's Provenge), whereas Stimuvax is an off-the-shelf product. Personalised vaccines are believed to work better.
The link below provides a thorough analysis into the Stimuvax trials to date (the reader comments on the article are enlightening as well). I do hope that the Stimuvax phase 3 trial is successful, however there is a real possibility that it may not be. If it fails, then I hope that the market realises that that does not mean that Cvac will automatically be a failure as well. Cvac's technology is different and its phase 2 results, I believe, offer a better likelihood of success.
http://www.thestreet.com/story/11179526/1/oncothyreon-deep-dive-into-stimuvax.html
- Forums
- ASX - By Stock
- IMM
- cvac and stimuvax - some perspective.
cvac and stimuvax - some perspective.
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
(20min delay)
|
|||||
Last
29.5¢ |
Change
0.005(1.72%) |
Mkt cap ! $428.5M |
Open | High | Low | Value | Volume |
28.5¢ | 30.5¢ | 28.5¢ | $469.8K | 1.579M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 297652 | 29.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
30.0¢ | 7500 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 297652 | 0.290 |
21 | 362622 | 0.285 |
34 | 1368572 | 0.280 |
6 | 196364 | 0.275 |
11 | 247398 | 0.270 |
Price($) | Vol. | No. |
---|---|---|
0.300 | 7500 | 2 |
0.305 | 242542 | 8 |
0.310 | 86126 | 5 |
0.320 | 6090 | 1 |
0.325 | 10000 | 1 |
Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |